Deregulated Bcl-2 gene expression selectively prolongs survival of growth factor-deprived hemopoietic cell lines - PubMed (original) (raw)
. 1990 May 1;144(9):3602-10.
Affiliations
- PMID: 2184193
Deregulated Bcl-2 gene expression selectively prolongs survival of growth factor-deprived hemopoietic cell lines
G Nuñez et al. J Immunol. 1990.
Abstract
The t(14;18) of human follicular B cell lymphoma translocates the Bcl-2 gene into the Ig H chain locus and markedly deregulates Bcl-2 expression. We sought to determine if Bcl-2 could be directly implicated in a growth-factor pathway. Consequently, we introduced a retrovirus containing the murine Bcl-2 gene (N2-M-Bcl-2) or the parental retrovirus (N2) into a series of factor-dependent hemopoietic cell lines. Overexpressed Bcl-2 resulted in no long term IL-2, IL-3, or IL-6 independent clones, indicating that Bcl-2 could not spare the need for a specific ligand-receptor interaction. However, Bcl-2 did extend the short term survival of IL-3-dependent cell lines after factor deprivation. Although viable, IL-3-deprived pro B lymphocytes (FL5.12) bearing N2-M-Bcl-2 were in Go, and deregulated Bcl-2 did not obviously influence cell-cycle progression. Bcl-2 predominant effects were to delay the onset of cell death and to modestly augment viable cell growth in the first 48 h after IL-3 deprivation. This death sparing was associated with increased levels of Bcl-2 RNA and protein in factor-deprived cells possessing N2-M-Bcl-2. This result was not restricted to prolymphocytes because an IL-3-dependent mast cell line (32D) as well as a promyeloid line (FDC-P1) demonstrated the same response to Bcl-2. Moreover, the effect was not limited to the IL-3/IL-3R signal transduction pathway in that promyeloid cells maintained in granulocyte-macrophage-CSF or IL-4 displayed a similar response. Yet, Bcl-2-enhanced cell survival was not universal as an IL-2-dependent T cell line, and an IL-6-dependent myeloma line demonstrated no consistent effect upon IL withdrawal. Thus, Bcl-2 appears to interfere with cell death but in a cell type and/or factor-restricted fashion.
Similar articles
- Regulatory effects of transforming growth factor-beta on IL-2- and IL-4-dependent T cell-cycle progression.
Ruegemer JJ, Ho SN, Augustine JA, Schlager JW, Bell MP, McKean DJ, Abraham RT. Ruegemer JJ, et al. J Immunol. 1990 Mar 1;144(5):1767-76. J Immunol. 1990. PMID: 2407783 - Molecular and cellular biology of interleukin-3.
Morris CF, Young IG, Hapel AJ. Morris CF, et al. Immunol Ser. 1990;49:177-214. Immunol Ser. 1990. PMID: 2090251 Review. - Control of programmed cell death in normal and leukemic cells: new implications for therapy.
Sachs L, Lotem J. Sachs L, et al. Blood. 1993 Jul 1;82(1):15-21. Blood. 1993. PMID: 8324219 Review.
Cited by
- Endoplasmic Reticulum Stress Signaling and Neuronal Cell Death.
Merighi A, Lossi L. Merighi A, et al. Int J Mol Sci. 2022 Dec 2;23(23):15186. doi: 10.3390/ijms232315186. Int J Mol Sci. 2022. PMID: 36499512 Free PMC article. Review. - Proteomic analysis reveals dual requirement for Grb2 and PLCγ1 interactions for BCR-FGFR1-Driven 8p11 cell proliferation.
Peiris MN, Meyer AN, Warda D, Campos AR, Donoghue DJ. Peiris MN, et al. Oncotarget. 2022 May 11;13:659-676. doi: 10.18632/oncotarget.28228. eCollection 2022. Oncotarget. 2022. PMID: 35574218 Free PMC article. - Regulation of Developmental Cell Death in the Animal Kingdom: A Critical Analysis of Epigenetic versus Genetic Factors.
Montero JA, Lorda-Diez CI, Hurle JM. Montero JA, et al. Int J Mol Sci. 2022 Jan 21;23(3):1154. doi: 10.3390/ijms23031154. Int J Mol Sci. 2022. PMID: 35163078 Free PMC article. Review. - NLRP3 inflammasome activation and cell death.
Huang Y, Xu W, Zhou R. Huang Y, et al. Cell Mol Immunol. 2021 Sep;18(9):2114-2127. doi: 10.1038/s41423-021-00740-6. Epub 2021 Jul 28. Cell Mol Immunol. 2021. PMID: 34321623 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources
Medical
Research Materials